ANIK Financial Facts
Licensing, milestone and contract revenue: 6KBasic weighted average common shares outstanding: 14.63M
See Full Income Statement
Total Assets: 231.06M
Intangible assets, net: 11.17M
See Full Balance Sheet
Anika Therapeutics Inc. (ANIK) Earnings
|
Expand Research on ANIK
| Next EPS Date | 8/5/26 | EPS Growth Rate | +115.4% |
|---|---|---|---|
| Average EPS % Beat Rate | +157.8% | Revenue Growth Rate | +3.5% |
| Average % Move 1-Wk after EPS | +2.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/5/26  |
Q226 | N/A | $0.02 | N/A | N/A | $29.21M | = | N/A | N/A | ||
| 4/29/26 | Q126 | $0.27 | -$0.18 | +$0.45 | $29.6M | $28.11M | = |  | | Details | |
| 2/26/26 | Q425 | $0.31 | -$0.14 | +$0.45 | $30.6M | $29.1M | = | | | Details | |
| 11/5/25 | Q325 | $0.04 | -$0.18 | +$0.22 | $27.8M | $27.8M | N/A | | | Details | |
| 7/30/25 | Q225 | -$0.13 | -$0.08 | -$0.05 | $28.22M | $28.15M | N/A | | | Details | |
| 5/9/25 | Q125 | -$0.06 | -$0.04 | -$0.02 | $26.17M | $28.13M | N/A | | | Details | |
| 3/12/25 | Q424 | -$0.03 | -$0.23 | +$0.20 | $30.6M | $29M | N/A | | | Details | |
| 2/27/25 |
Q424 | N/A | $0.23 | N/A | N/A | $45.72M | = | N/A | N/A |
